Dr. Asif Riaz Khan – Medical Oncologist

Dr. Asif Riaz Khan is a consultant Medical Oncologist and cancer specialist in Peshawar with extensive clinical experience in the diagnosis and medical management of different types of cancer. His qualifications include MBBS, FCPS (Medical Oncology), MRCP (UK), FRACGP (Australia), and SCE (Medical Oncology, UK).

He provides cancer care at Life Care Hospital & Research Institute, Hayatabad, Peshawar, where patients can consult him for cancer assessment, diagnosis and staging, systemic cancer treatment, treatment planning, and ongoing oncology care.

Dr. Asif Riaz Khan’s clinical work includes the management of solid tumors as well as hematological malignancies. His areas of focus include breast, lung and gastrointestinal cancers, alongside blood cancers such as leukemia and lymphoma. His oncology practice incorporates conventional chemotherapy as well as newer systemic treatments including immunotherapy and molecular targeted therapies when clinically appropriate.

Qualifications of Dr. Asif Riaz Khan

Dr. Asif Riaz Khan holds the following professional qualifications:

• MBBS – Bachelor of Medicine, Bachelor of Surgery
• FCPS (Medical Oncology) – Fellowship in Medical Oncology, Pakistan
• MRCP (UK) – Membership of the Royal Colleges of Physicians of the United Kingdom
• FRACGP (Australia) – Fellowship of the Royal Australian College of General Practitioners
• SCE (Medical Oncology, UK) – Specialty Certificate Examination in Medical Oncology

His training includes a specialized oncology fellowship at Fauji Foundation Hospital and subsequent senior clinical work in oncology.

Dr. Asif Riaz Khan’s Specialties

His main areas of clinical interest and expertise include:

• Medical oncology
• Cancer diagnosis and staging
• Breast cancer
• Lung cancer
• Gastrointestinal cancers
• Colorectal cancer
• Liver cancer
• Hematological malignancies
• Leukemia
• Lymphoma
• Solid tumors
• Advanced and metastatic cancers
• Chemotherapy
• Immunotherapy
• Targeted cancer therapy
• Precision oncology
• Cancer treatment planning
• Supportive cancer care

Cancer Diagnosis and Treatment

Cancer treatment varies considerably depending on the type of cancer, its stage, molecular characteristics, the patient’s general health, previous treatments, and other individual factors.

As a medical oncologist, Dr. Asif Riaz Khan evaluates patients and helps develop individualized cancer treatment plans. His clinical services include cancer diagnosis and staging as well as systemic cancer therapies.

Chemotherapy

Chemotherapy uses medicines to destroy cancer cells or interfere with their growth. It may be used alone or alongside surgery, radiotherapy, immunotherapy, or other treatments depending on the cancer.

A medical oncologist determines whether chemotherapy is appropriate, selects suitable medicines and treatment schedules, and monitors the patient’s response and possible side effects.

Immunotherapy

Immunotherapy helps the body’s immune system recognize or attack certain cancers. It has become an important treatment option for selected patients with several types of cancer.

Not every cancer or patient is suitable for immunotherapy. Decisions may depend on cancer type, stage, biomarkers, previous treatment, and overall clinical condition.

Targeted Therapy

Targeted therapies act on specific molecular characteristics or pathways involved in the growth and survival of cancer cells.

Where appropriate, molecular or biomarker testing may help oncologists determine whether a patient could benefit from a particular targeted treatment.

Solid Tumor Management

Dr. Asif Riaz Khan’s oncology practice includes the management of solid tumors, with particular clinical focus on breast, lung and gastrointestinal cancers.

Patients may be referred to a medical oncologist after a suspicious mass is detected, following a biopsy confirming cancer, after cancer surgery, or when imaging indicates that a malignancy may have spread.

The oncologist works with pathology reports, imaging, laboratory investigations and other clinical findings to determine the appropriate treatment strategy.

Blood Cancers

His clinical scope also includes advanced hematological malignancies, including leukemia and lymphoma.

Blood cancers can require specialized investigations and treatment strategies that differ significantly from those used for many solid tumors. Treatment may involve chemotherapy, targeted medicines, immunotherapy, supportive care, or referral for additional specialized procedures depending on the diagnosis.

Research and Academic Involvement

Dr. Asif Riaz Khan has also contributed to published medical research.

He is a co-author of a 2026 case report concerning metastatic acral melanoma with retroperitoneal and liver metastases, with his affiliation recorded as the Department of Medical Oncology at Life Care Hospital & Research Institute, Peshawar.

He also contributed to research published in the Journal of Pain & Palliative Care Pharmacotherapy examining prophylactic histamine blockade for filgrastim-induced bone pain in female cancer patients. His affiliation in this research is likewise given as the Department of Medical Oncology at Life Care Hospital & Research Institute, Peshawar.

This research involvement complements his clinical work in cancer treatment and supportive oncology care.

When Should You Consult a Medical Oncologist?

A consultation with a medical oncologist may be appropriate when:

• A biopsy has confirmed cancer
• Imaging suggests a possible malignancy
• Cancer has recently been diagnosed
• Chemotherapy has been recommended
• Immunotherapy or targeted therapy is being considered
• Cancer has returned after previous treatment
• Cancer has spread to other parts of the body
• A second opinion about a cancer treatment plan is needed
• Treatment side effects require oncology assessment
• Ongoing monitoring is required following cancer treatment

Patients with a new cancer diagnosis may require care from several specialists, including surgeons, medical oncologists, radiation oncologists, radiologists, pathologists and other healthcare professionals depending on the type and stage of cancer.